![Philip Vickers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Vickers
Director/Board Member at
AKEBIA THERAPEUTICS, INC.
Profile
Philip J.
Vickers currently serves as President, Chief Executive Officer & Director at Solu Therapeutics, Inc., Director at Northern Mosaic LP, and Director at Akebia Therapeutics, Inc. (starting 2026).
Former roles include President, Chief Executive Officer & Director at Northern Biologics, Inc. (2017–2020), President, Chief Executive Officer & Director at Faze Medicines, Inc. (2021–2022), President, Director & Chief Scientific Officer at Resolvyx Pharmaceuticals, Inc. (2009–2011), Independent Director at Revance Therapeutics, Inc. (2015–2023), Director at Neusentis Ltd., Independent Director at AVROBIO, Inc. (2019–2024), Global Head-Research & Development at Shire Plc (2013–2017), Principal at Boehringer Ingelheim Corp., VP & Head-Pfizer Research Technology Center at Pfizer (St. Louis), and Principal at Merck Research Laboratories Massachusetts LLC.
Education includes undergraduate studies at the University of Salford and a doctorate from the University of Toronto.
Philip Vickers active positions
| Companies | Position | Start |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Director/Board Member | 2026-03-31 |
Northern Mosaic LP
 Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Provides biotechnology technology services | Director/Board Member | - |
Solu Therapeutics
 Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Chief Executive Officer | 2023-08-31 |
Former positions of Philip Vickers
| Companies | Position | End |
|---|---|---|
| TECTONIC THERAPEUTIC, INC. | Director/Board Member | 2024-05-19 |
| REVANCE THERAPEUTICS, INC. | Director/Board Member | 2023-05-02 |
Faze Medicines, Inc. /MA)
 Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Provides business services | Chief Executive Officer | 2022-10-31 |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Chief Executive Officer | 2020-11-30 |
| SHIRE | Chief Tech/Sci/R&D Officer | 2017-05-31 |
Training of Philip Vickers
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Resolvyx Pharmaceuticals, Inc.
 Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for inflammatory diseases | Health Technology |
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
University of Salford
 University of Salford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Neusentis Ltd.
 Neusentis Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in other business support service activities | Commercial Services |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Health Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Provides biotechnology technology services | Commercial Services |
Faze Medicines, Inc. /MA)
Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Provides business services | Commercial Services |
Solu Therapeutics
Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Health Technology |
- Stock Market
- Insiders
- Philip Vickers
